A single dose of pegfilgrastim compared with daily filgrastim for supporting neutrophil recovery in patients treated for low-to-intermediate risk acute myeloid leukemia: results from a randomized, double-blind, phase 2 trial

A single dose of pegfilgrastim compared with daily filgrastim for supporting neutrophil recovery in patients treated for low-to-intermediate risk acute myeloid leukemia: results from a randomized, double-blind, phase 2 trial

Item

http://www.wikidata.org/entity/Q33350688

Q33350688

about

PEGylation of Interferon-β-1a Phase II, randomized, open-label study of pegfilgrastim-supported VDC/IE chemotherapy in pediatric sarcoma patients The effect of recombinant granulocyte colony-stimulating factor on oral and periodontal manifestations in a patient with cyclic neutropenia: a case report Assessment and management of febrile neutropenia in emergency departments within a regional health authority-a benchmark analysis Pegfilgrastim and daily granulocyte colony-stimulating factor: patterns of use and neutropenia-related outcomes in cancer patients in Spain--results of the LEARN Study.Pharmacokinetics and pharmacodynamics of pegfilgrastim.Neutropenia-associated outcomes in adults with acute myeloid leukemia receiving cytarabine consolidation chemotherapy with or without granulocyte colony-stimulating factor.Prevention of chemotherapy-induced neutropenia with pegfilgrastim: pharmacokinetics and patient outcomes.Granulocyte colony-stimulating factors as prophylaxis against febrile neutropenia.Prophylactic long-acting granulocyte-colony stimulating factors (G-CSF) in gynecologic malignancies: an oncologic expert statement.Acute myeloid leukemia in the elderly (age 70 yr or older): long-term survivors.Intensive consolidation with G-CSF support: Tolerability, safety, reduced hospitalization, and efficacy in acute myeloid leukemia patients ≥60 years.Condensed versus standard schedule of high-dose cytarabine consolidation therapy with pegfilgrastim growth factor support in acute myeloid leukemia.Prophylaxis of infectious complications with colony-stimulating factors in adult cancer patients undergoing chemotherapy-evidence-based guidelines from the Infectious Diseases Working Party AGIHO of the German Society for Haematology and Medical Onc A single dose pegfilgrastim for supporting neutrophil recovery in patients treated for high-risk acute myeloid leukemia by the EMA 2000 schedule.Impact of pegylated filgrastim in comparison to filgrastim for patients with acute myeloid leukaemia (AML) on high-dose cytarabine (HIDAC) consolidation chemotherapy.SEIFEM 2017: from real life to an agreement on the use of granulocyte transfusions and colony-stimulating factors for prophylaxis and treatment of infectious complications in patients with hematologic malignant disorders.Comparison and modelling of pegylated or unpegylated G-CSF schedules in CHOP-14 regimen of elderly patients with aggressive B-cell lymphoma.Systematic Review and Meta-analysis of Short- versus Long-Acting Granulocyte Colony-Stimulating Factors for Reduction of Chemotherapy-Induced Febrile Neutropenia

P2860

Q22241420-1AC6F98E-6657-4BD7-BC49-62AB08FDCE71 Q24632145-A5A6F317-9D61-47A1-90B1-27E9A4C7F956 Q33720979-D371E451-D08C-4D53-938D-9B147BCDD3E2 Q35572998-334081CE-25AC-463B-802E-D569D7053930 Q37241723-C7EF0085-86DB-4AAB-8DA4-BF026A95B745 Q37860299-023A9803-E8F5-4412-9E6C-267873036E43 Q38064808-629B7D1A-2706-4AE2-9BDD-5166C65A6234 Q38072290-30035D40-6327-4D7F-9ECB-F2F0CAC9CBC0 Q38256944-75E3993D-0404-469F-8A34-1257960571B7 Q38608267-9C8C73AF-7156-45D8-A079-637B8EC2E27C Q39311595-D28CAF3B-FD0D-4DD8-859B-675075A54B27 Q40138696-D540568C-47F1-466E-AE3A-5C93921081BD Q40197450-DF4556EF-C7D6-45EF-AA51-0B5963240EA5 Q42223844-F71110CC-0D3D-4BBA-8007-86404CC7E6AB Q43014789-A98266CF-FF4B-4D7E-A622-62FBF2DF8861 Q44799963-C81CFDAE-7E30-44A5-9A61-BA8FABD75011 Q47235713-172051CC-A0D4-480D-BBB8-554AE41DE2C4 Q47918300-82C63F37-4563-4A21-9844-732DFEA79D84 Q57292845-8D46321E-4350-4007-9788-0E9ED26B8CA6

P2860

A single dose of pegfilgrastim compared with daily filgrastim for supporting neutrophil recovery in patients treated for low-to-intermediate risk acute myeloid leukemia: results from a randomized, double-blind, phase 2 trial

Item

http://www.wikidata.org/entity/Q33350688

description

2008 nî lūn-bûn

@nan

2008 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2008 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu